Table 5.
Neonatal metabolic gene stimulation is prevented by GVAD and Cyp1b1 deletion
| Fold change upper versus | Weaning LF12 | GVAD | Cyp1b1−/− LF12 | Cyp1b1−/− GVAD |
|---|---|---|---|---|
| lower | Birth LF12 | LF12 | LF12 | Cyp1b1−/− LF12 |
| Hamp2 | 187.1** | −50.2** | −28.0** | 3.7** |
| Fatty Acid Synthesis | ||||
| Srebp-1c | 4.9** | n.s. | n.s. | n.s. |
| Mlxipl/Chrebp | 4.4** | n.s. | −2.6** | n.s. |
| Srebp2 | 1.5 | n.s. | −1.5* | 2.0** |
| Acaca | 7.6** | −2.4** | −3.7** | 1.5** |
| Acacb | 7.9** | −3.0** | −12.3** | 1.7* |
| Me1 | 8.4** | −4.1** | −3.6** | 1.4* |
| Fasn | 28.3** | −3.3** | −12.2** | 2.7** |
| Scd1 | 86.9** | −4.3** | −12.2** | 1.9 |
| Elovl6 | 6.0** | −5.3** | −27.8** | 2.8** |
| Acly | 10.8** | −2.6** | −8.4** | 1.5* |
| Mup4 a | 73.8** | −3.9** | −7.3** | 2.2** |
| Thrsp | 136.6** | −1.7 | −10.0** | 4.6** |
| Cholesterol Metabolism | ||||
| Acss2 | 8.6** | −3.5** | −7.0** | 2.4** |
| Aacs | 10.4** | −2.7** | −17.5** | 4.5** |
| Idi1 | 4.7** | −1.6* | −10.6** | 10.1** |
| Sqle | 2.4* | −2.2** | −23.0** | 26.0** |
| Hmgcr | 4.0** | n.s. | −6.4** | 4.2** |
| Lss | 1.7* | n.s. | −3.4** | 5.0** |
| Hmgcs1 | 3.5** | n.s. | −4.7** | 3.8** |
| Cyp51 | 2.3* | −1.9* | −5.8** | 7.2** |
| Fdps | 4.1** | n.s. | −6.8** | 8.0** |
| Sc4mol | 3.5* | n.s. | −7.1** | 7.9** |
| Fdft1 | 3.1** | n.s. | −1.9 | 2.2** |
| Dhcr7 | 3.7** | −1.6 | −5.8** | 3.6** |
| Gadd45γ | 6.2** | −6.7** | −6.5** | 2.1 |
| Ppp1r3g | 1.5 | −9.4** | −7.3** | n.s. |
Additional Mup genes that follow the same expression pattern include: Mup1, Mup3, and Mup5
p-value ≤ 0.05
p-value ≤ 0.01
n.s. Non-significant values, FC<1.5 and p-value>0.05